Poster Presentations (Mon, 26 Sep, 14:00-16:30) Lung Cancer – Metastatic
9101 POSTER Pre-planned Subgroup Analyses From the Phase III, Randomised, Placebo-controlled, Parallel-group Study of Gefitinib (G) as Maintenance Therapy in Patients (pts) With Locally Advanced or Metastatic Non-small-cell Lung Cancer (NSCLC) (INFORM; C-TONG 0804)